845 related articles for article (PubMed ID: 10468952)
1. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
[TBL] [Abstract][Full Text] [Related]
3. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
4. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS
Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
[TBL] [Abstract][Full Text] [Related]
5. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
[TBL] [Abstract][Full Text] [Related]
6. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
[TBL] [Abstract][Full Text] [Related]
7. Women With Turner Syndrome Are Both Estrogen and Androgen Deficient: The Impact of Hormone Replacement Therapy.
Viuff MH; Just J; Brun S; Dam TV; Hansen M; Melgaard L; Hougaard DM; Lappe M; Gravholt CH
J Clin Endocrinol Metab; 2022 Jun; 107(7):1983-1993. PubMed ID: 35302622
[TBL] [Abstract][Full Text] [Related]
8. Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.
Gravholt CH; Frystyk J; Flyvbjerg A; Orskov H; Christiansen JS
Am J Physiol Endocrinol Metab; 2001 Feb; 280(2):E308-14. PubMed ID: 11158935
[TBL] [Abstract][Full Text] [Related]
9. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
10. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
Lukanova A; Lundin E; Zeleniuch-Jacquotte A; Muti P; Mure A; Rinaldi S; Dossus L; Micheli A; Arslan A; Lenner P; Shore RE; Krogh V; Koenig KL; Riboli E; Berrino F; Hallmans G; Stattin P; Toniolo P; Kaaks R
Eur J Endocrinol; 2004 Feb; 150(2):161-71. PubMed ID: 14763914
[TBL] [Abstract][Full Text] [Related]
11. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V
Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670
[TBL] [Abstract][Full Text] [Related]
12. Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult Turner syndrome: the impact of body composition, maximal oxygen uptake and treatment with sex hormones.
Gravholt CH; Veldhuis JD; Christiansen JS
Growth Horm IGF Res; 1998 Aug; 8(4):289-98. PubMed ID: 10984320
[TBL] [Abstract][Full Text] [Related]
13. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort.
Leifke E; Gorenoi V; Wichers C; Von Zur Mühlen A; Von Büren E; Brabant G
Clin Endocrinol (Oxf); 2000 Dec; 53(6):689-95. PubMed ID: 11155090
[TBL] [Abstract][Full Text] [Related]
15. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
Milewicz T; Krzysiek J; Janczak-Saif A; Sztefko K; Krzyczkowska-Sendrakowska M
Endokrynol Pol; 2005; 56(6):883-90. PubMed ID: 16821206
[TBL] [Abstract][Full Text] [Related]
16. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
17. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
Lønning PE; Helle SI; Johannessen DC; Adlercreutz H; Lien EA; Tally M; Ekse D; Fotsis T; Anker GB; Hall K
Clin Endocrinol (Oxf); 1995 Jan; 42(1):23-30. PubMed ID: 7534218
[TBL] [Abstract][Full Text] [Related]
18. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264
[TBL] [Abstract][Full Text] [Related]
19. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
Bannink EM; van Sassen C; van Buuren S; de Jong FH; Lequin M; Mulder PG; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
[TBL] [Abstract][Full Text] [Related]
20. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
